Page 73 - BSAVA Guide to Pain Management in Small Animal Practice
P. 73

BSAVA Guide to Pain Management in Small Animal Practice



        VetBooks.ir  intraoperatively as part of a balanced   which can result in remodelling of the central
              Low-dose intravenous infusions are useful
                                                  nervous system and ultimately alter the animal’s
                                                  perception of future painful and non-painful
           anaesthesia technique to reduce anaesthetic
           requirements and postoperatively to provide   stimuli (central sensitization). Drugs that
           titratable sedation and analgesia.     antagonize NMDA receptors are analgesic and
            exmedetomidine infusion  1  g kg hour  has   can also help prevent central sensitization,
           been shown to be as e ective to a morphine   secondary hyperalgesia and chronic pain.
           infusion   .1 mg kg hour  for providing
           analgesia following major surgery in dogs   Ketamine
           without adverse e ects  Valtolina et al.,    9 .   Ketamine is a dissociative anaesthetic and
           Dogs receiving dexmedetomidine in this study   analgesic that antagonizes NMDA receptors in
           had lower heart rates and higher diastolic blood   the central nervous system. It also acts at other
           pressure than dogs receiving morphine, but   receptors including opioid receptors, and
           these were still within acceptable ranges. The   inhibits serotonin and dopamine reuptake.
           cardiovascular e ects of an infusion are less    etamine is now a Schedule   Controlled  rug
           severe than those that occur following   in the UK and must be kept in a locked
           intravenous or intramuscular injection of a bolus   cupboard with detailed records of its acquisition
           dose. Suggested doses for clinical use are 1     and use.
            g kg hour for medetomidine and  .     g
           kg/hour for dexmedetomidine, although the   Effects: Ketamine’s properties and uses vary
           dose can be adjusted to achieve the desired   with dose. At doses greater than   mg kg
           e ect.  o achieve an appropriate plasma   intravenously or intramuscularly it can be used
           concentration of the drug quickly, an initial   to induce dissociative anaesthesia, at lower
           intravenous bolus is usually recommended. The   doses it can be used as part of a sedation
           aim should be a calm patient that can still   protocol, and at very low doses   .  1 mg kg  it
           function normally, i.e. eat, drink and ambulate,   is an e ective somatic analgesic. Because of its
           unless more profound sedation is required.   adverse e ects  dysphoria, excitement,
           Volumes used are very small so the solution   increased muscle tone, seizures in dogs),
           must be diluted carefully, and an infusion pump   ketamine should not be used alone except at
           or syringe driver should be used.      very low doses, and it is usually combined with
              In locoregional anaesthesia, addition of   an alpha   agonist or ben odia epine for this
           alpha   agonists to the local anaesthetic   reason. It can cause increased salivation and
           solution signi cantly prolongs the duration of   nausea.  etamine has several bene cial e ects
           e ect.  or example, a techni ue for sciatic and   compared with other induction agents: it
           femoral nerve blocks using dexmedetomidine   maintains cardiac output and blood pressure
             .1  g kg for each block  combined with   due to its sympathomimetic e ects with little
           bupivacaine has been described (Bartel et al.,   e ect on blood vessels. It also causes
             16 .  nly preservative free solutions should   bronchodilation, preserves laryngeal re exes
           be used for epidural or spinal anaesthesia.  and patients usually breathe well. However,
                                                  ketamine increases cerebral blood  ow and
           NMDA receptor antagonists              cerebral oxygen demand, which may result in
           N-methyl- -aspartate (NMDA) receptors are   increased intracranial pressure. Used alone, it
           located in the brain and spinal cord. Activation   increases intraocular pressure. In dogs,
           occurs after repeated or widespread input from   ketamine is metabolized in the liver
           a erent neurones carrying nociceptive signals   (norketamine is an active metabolite) and
           (temporal and spatial summation). NMDA   excreted in urine; in cats, it is mostly excreted
           receptor activation results in prolonged   unchanged in urine and therefore its
           depolarization of second order dorsal horn   e ects may be prolonged in cats with
           neurones, a phenomenon known as ‘wind-up’,   renal insu ciency.

           68



         Ch05 Pain Management.indd   68                                         19/12/2018   10:36
   68   69   70   71   72   73   74   75   76   77   78